In August 2019, the Governor of Oregon signed into law HB 3273, requiring manufacturers of covered drugs to develop and implement a drug take-back program by July 1, 2021, and submit plans for participating in a program by Nov. 1, 2020.

According to the Product Stewardship Institute, Oregon is the sixth state to require manufacturers to fund and safely manage drug take-back, preceded by Massachusetts, Vermont, Washington, New York, and California.